Pediatric Vaccines Market Research Report: Information By Type (Monovalent Vaccines and Multivalent Vaccines), By Technology (Live Attenuated, Inactivated, Subunits, Toxoids, Conjugates and Others), By Application (Polio, Diphtheria-Tetanus-Acellular Pertussis, Haemophilus Influenzae Type B, MMR, Hepatitis B, Pneumococcal Vaccine and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL VEIN ILLUMINATOR MARKET, BY TYPE

6.1. Overview

6.2. Monovalent Vaccines

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Multivalent Vaccines

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL VEIN ILLUMINATOR MARKET, BY TECHNOLOGY

7.1. Overview

7.2. Live Attenuated

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Inactivated

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Subunits

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5. Toxoids

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6. Conjugates

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL VEIN ILLUMINATOR MARKET, BY APPLICATION

8.1. Overview

8.2. Polio

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Diphtheria-Tetanus-Acellular Pertussis (DTaP)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Haemophilus Influenzae Type B (Hib)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5. MMR (Mumps, Measles, and Rubella)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6. Hepatitis B

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.7. Pneumococcal Vaccine

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.8. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9. GLOBAL VEIN ILLUMINATOR MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1.1. Overview

10.1.2. Competitive Analysis

11. COMPANY PROFILE

11.1. Sanofi S.A.

11.1.1. Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. GlaxoSmithKline plc

11.2.1. Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Merck & Co., Inc.

11.3.1. Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Pfizer Inc.

11.4.1. Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Grifols

11.5.1. Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Serum Institute of India Pvt. Ltd

11.6.1. Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. AstraZeneca

11.7.1. Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Cadila Healthcare Ltd

11.8.1. Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Indian Immunologicals Limited

11.9.1. Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. CSL Limited

11.10.1. Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Others

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL VEIN ILLUMINATOR MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL VEIN ILLUMINATOR MARKET ESTIMATES AND FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL VEIN ILLUMINATOR MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 10 US: VEIN ILLUMINATOR MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 11 US: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 12 US: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 13 CANADA: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 14 CANADA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 15 CANADA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 16 LATIN AMERICA: VEIN ILLUMINATOR MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 17 LATIN AMERICA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 18 LATIN AMERICA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 19 EUROPE: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 20 EUROPE: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 21 EUROPE: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL VEIN ILLUMINATOR MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL VEIN ILLUMINATOR MARKET

FIGURE 4 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY TECHNOLOGY, 2020 (%)

FIGURE 6 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: VEIN ILLUMINATOR MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 9 EUROPE: VEIN ILLUMINATOR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 WESTERN EUROPE: VEIN ILLUMINATOR MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 13 GLOBAL VEIN ILLUMINATOR MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 SANOFI S.A.: KEY FINANCIALS

FIGURE 15 SANOFI S.A.: SEGMENTAL REVENUE

FIGURE 16 SANOFI S.A.: REGIONAL REVENUE

FIGURE 17 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 18 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 19 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 20 MERCK & CO., INC.: KEY FINANCIALS

FIGURE 21 MERCK & CO., INC.: SEGMENTAL REVENUE

FIGURE 22 MERCK & CO., INC.: REGIONAL REVENUE

FIGURE 23 PFIZER INC.: KEY FINANCIALS

FIGURE 24 PFIZER INC.: SEGMENTAL REVENUE

FIGURE 25 PFIZER INC.: REGIONAL REVENUE

FIGURE 26 GRIFOLS: KEY FINANCIALS

FIGURE 27 GRIFOLS: SEGMENTAL REVENUE

FIGURE 28 GRIFOLS: REGIONAL REVENUE

FIGURE 29 SERUM INSTITUTE OF INDIA PVT. LTD: KEY FINANCIALS

FIGURE 30 SERUM INSTITUTE OF INDIA PVT. LTD: SEGMENTAL REVENUE

FIGURE 31 SERUM INSTITUTE OF INDIA PVT. LTD: REGIONAL REVENUE

FIGURE 32 ASTRAZENECA: KEY FINANCIALS

FIGURE 33 ASTRAZENECA: SEGMENTAL REVENUE

FIGURE 34 ASTRAZENECA: REGIONAL REVENUE

FIGURE 35 CADILA HEALTHCARE LTD: KEY FINANCIALS

FIGURE 36 CADILA HEALTHCARE LTD: SEGMENTAL REVENUE

FIGURE 37 CADILA HEALTHCARE LTD: REGIONAL REVENUE

FIGURE 38 INDIAN IMMUNOLOGICALS LIMITED: KEY FINANCIALS

FIGURE 39 INDIAN IMMUNOLOGICALS LIMITED: SEGMENTAL REVENUE

FIGURE 40 INDIAN IMMUNOLOGICALS LIMITED: REGIONAL REVENUE

FIGURE 41 CSL LIMITED: KEY FINANCIALS

FIGURE 42 CSL LIMITED: SEGMENTAL REVENUE

FIGURE 43 CSL LIMITED: REGIONAL REVENUE